Sunzen Biotech Bhd (XKLS:0148) Change In Payables And Accrued Expense

: RM0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

Sunzen Biotech Bhd's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was RM0.00 Mil. It means Sunzen Biotech Bhd's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Sep. 2023 .

Sunzen Biotech Bhd's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was RM0.00 Mil. It means Sunzen Biotech Bhd's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .

Sunzen Biotech Bhd Change In Payables And Accrued Expense Historical Data

The historical data trend for Sunzen Biotech Bhd's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunzen Biotech Bhd Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Sunzen Biotech Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Payables And Accrued Expense																-	-	-	-	-

Sunzen Biotech Bhd Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00 Mil.

Sunzen Biotech Bhd Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sunzen Biotech Bhd's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunzen Biotech Bhd (XKLS:0148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sunzen Biotech Bhd (XKLS:0148) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, Jalan Anggerik Mokara 31/47, Kota Kemuning, Shah Alam, SGR, MYS, 40460

Website

https://www.sunzen.com.my

Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.

Sunzen Biotech Bhd (XKLS:0148) Headlines

No Headlines